Concepedia

Salil Putatunda

SP

5

Publications

128

Citations

5

H-Index

2012

Active since

Affiliations

Bose Institute(Current)

Salil Putatunda is an author at Bose Institute specializing in tumor biology, natural sciences, and tumor microenvironment.

ORCID

Top concepts

Publications per year

2012–2019

5

Publications

5

Proline bulky substituents consecutively act as steric hindrances and directing groups in a Michael/Conia-ene cascade reaction under synergistic catalysis

Salil Putatunda, Juan V. Alegre‐Requena, Marta Meazza et al. · Chemical Science · 2019 · 39 citations · Full text

Cross-talk between Endoplasmic Reticulum (ER) Stress and the MEK/ERK Pathway Potentiates Apoptosis in Human Triple Negative Breast Carcinoma Cells

Swatilekha Ghosh, Arghya Adhikary, Supriya Chakraborty et al. · Journal of Biological Chemistry · 2014 · 31 citations · Full text

Nifetepimine, a Dihydropyrimidone, Ensures CD4+ T Cell Survival in a Tumor Microenvironment by Maneuvering Sarco(endo)plasmic Reticulum Ca2+ ATPase (SERCA)

Swatilekha Ghosh, Arghya Adhikary, Samik Chakraborty et al. · Journal of Biological Chemistry · 2012 · 25 citations · Full text

, , +7

Regioselective N1-alkylation of 3,4-dihydropyrimidine-2(1H)-ones: Screening of their biological activities against Ca2+-ATPase

Salil Putatunda, Srabasti Chakraborty, Swatilekha Ghosh et al. · European Journal of Medicinal Chemistry · 2012 · 22 citations

, , +4

Formulation and antitumorigenic activities of nanoencapsulated nifetepimine: A promising approach in treating triple negative breast carcinoma

Aparajita Ghosh, Arijit Bhowmik, Suman Bhandary et al. · Nanomedicine Nanotechnology Biology and Medicine · 2016 · 11 citations

Rows per page

1–5 of 5